Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00971568 · ClinicalTrials.gov registry record
Urinary Biomarkers Characteristic to Interstitial Cystitis
A clinical trial of Interstitial Cystitis, sponsored by Corewell Health East.
- Completed
- Registry status
- 15
- Enrollment target
- 1
- Study location
NCT00971568 is a study of Interstitial Cystitis that has completed, run by Corewell Health East. The registered enrollment target is 15 participants, below the 362-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00971568, a study of Interstitial Cystitis, has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a retrospective study of urine samples stored in the Beaumont BioBank for future research. The urine samples will be drawn from the urine back with patients previously diagnosed with severe interstitial cystitis (IC), mild IC and no IC. Interstitial Cystitis (IC) also known as Painful Bladder Syndrome (PBS) is a chronic inflammatory disease. It has an unknown etiology, symptoms which present to varying degrees, as well as an uncertain natural history. Diagnosis of IC is based on symptoms after excluding more common and dangerous pathologies.
Conditions Studied
Study Locations (1)
Michigan
- Beaumont Hospitals-Royal Oak - Royal Oak
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-09 |
| Est. Completion | 2011-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00971568
The ClinicalTrials.gov registry entry for NCT00971568 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 362-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (96% lower). The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Interstitial Cystitis appearing as the primary indexed condition, and to 0 interventions.
NCT00971568 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT00971568 about?
NCT00971568 is a clinical study titled "Urinary Biomarkers Characteristic to Interstitial Cystitis". This is a retrospective study of urine samples stored in the Beaumont BioBank for future research. The urine samples will be drawn from the urine back with patients previously diagnosed with severe interstitial cystitis (IC), mild IC and no IC. Interstitial Cystitis (IC) also known as Painful Bladd...
What is the current status of trial NCT00971568?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2009-09. Estimated completion is 2011-09.
What conditions does trial NCT00971568 study?
This clinical trial studies the following conditions: Interstitial Cystitis.
Who is sponsoring clinical trial NCT00971568?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00971568 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Interstitial Cystitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
RECRUITING · NA
-
Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome
RECRUITING · Phase 1
-
Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome
RECRUITING · NA
-
Identifying Genetic Causes of IC/BPS
RECRUITING
-
EPPIC: Easing Pelvic Pain Interventions Clinical Research Program
RECRUITING · NA
-
Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.